Quality by design endorsed fabrication of Ibrutinib-loaded human serum albumin nanoparticles for the management of leukemia
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science,General Medicine,Biotechnology
Reference38 articles.
1. The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019;Yao;Biomed. Eng. Online,2022
2. The American Cancer Society, Key Statistics for Chronic Lymphocytic Leukemia, (https://www.cancer.org/content/dam/CRC/PDF/Public/8679.00.pdf); Accessed on 18-07-2023.
3. Ibrutinib and venetoclax for first-line treatment of CLL;Jain;N. Engl. J. Med.,2019
4. Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL;Woyach;N. Engl. J. Med.,2018
5. Ibrutinib in chronic lymphocytic leukemia: clinical applications, drug resistance, and prospects;Zhou;Onco. Targets. Ther.,2020
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Raloxifene loaded d-α-tocopherol polyethylene glycol 1000 succinate stabilized poly (ε-caprolactone) nanoparticles augmented drug delivery and apoptosis in breast cancer cells;Journal of Drug Delivery Science and Technology;2024-02
2. Quality by design fostered fabrication of cabazitaxel loaded pH-responsive Improved nanotherapeutics against prostate cancer;Colloids and Surfaces B: Biointerfaces;2024-02
3. Fucoidan-mediated targeted delivery of dasatinib-loaded nanoparticles amplifies apoptosis and endows cytotoxic potential in triple-negative breast cancer;Colloids and Surfaces B: Biointerfaces;2024-01
4. Quality by Design Galvanized development of resveratrol loaded PLGA nanoparticles: In vitro and Ex vivo evaluation for the non-invasive treatment of metastatic melanoma;Journal of Drug Delivery Science and Technology;2024-01
5. Quality by design endorsed atorvastatin-loaded nanostructured lipid carriers embedded in pH-responsive gel for melanoma;Journal of Microencapsulation;2023-12-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3